Multiple Myeloma – Sagar Lonial, MD, and Robert Figlin, MD, discuss clinical highlights from ASH 2018

Wednesday December 12, 2018

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Sagar Lonial, MD, Professor and Chair, Hematology & Medical Oncology, Chief Medical Officer, Winship Cancer Institute of Emory University, discuss ALCYONE, GRIFFIN, and maintenance therapy (TOURMALINE-MM3), and other multiple myeloma clinical studies presented at the American Society of Hematology 2018 meeting

Featured Videos

Parameswaran Hari, MD, MRCP, tells us about the design & outcomes of the STORM and Mammoth studies

Amrita Krishnan, MD, tells us about the outcomes of the CARTITUDE-1 study presented at ASH 2019

Noa Biran, MD, provides her impression of the Phase 3 ICARIA-MM study